Lox as the Potential Key Gene of Clear Cell Renal Carcinoma

被引:0
|
作者
Chen, Yanru [1 ]
Yan, Zhangzhe [2 ]
Su, Yanping [1 ]
Zhao, Shang [3 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Dept Histol & Embryol, Yingshengdong Rd, Tai An, Shandong, Peoples R China
[2] Shandong First Med Univ, Dept Gastroenterol, Canc Hosp, Jiyan Rd, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ & Shandong Acad Med Sci, Dept Pathophysiol, Yingshengdong Rd, Tai An, Shandong, Peoples R China
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2022年 / 32卷 / 05期
基金
中国国家自然科学基金;
关键词
Renal clear cell carcinoma; Microarray datasets; Bioinformatics approach; Prognostic factor; LOX; LYSYL OXIDASE; CANCER; PROGRESSION; THERAPY;
D O I
10.29271/jcpsp.2022.05.632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clear cell renal carcinoma (CCRC) is the most common type of renal carcinoma. We hope to find out the potential key genes playing important roles in CCRC genesis and progression by analysing the recent expression profiling by array from 2014 to 2016. In order to find out the differentially expressed genes (DEGs) between CCRC and normal renal tissue. Gene Ontology (GO) and Kyoto Encyclopedia of Genes, and Genomes (KEGG) pathway enrichment were carried out by the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8. Protein-Protein Interaction (PPI) Networks Functional Enrichment Analysis of these DEGs was analyzed using the Search Tool for Recurring Instances of Neighbouring Genes (STRING). The results were then visualized by the software Cytoscape. The authors also used the online tool of Kaplan-Meier plotter survival analysis to assess the significance of the top ten genes in the prognosis of CCRC. A total of 192 DEGs were identified and the top ten key genes were picked out by the software Cytoscape. FN1, CXCR4, LOX, and PLG were then further screened out based on the overall survival analysis; SLC12A1 and LOX were screened out after the recurrence-free survival analysis. LOX was finally believed to be the most reliable prognostic factor since it has prognostic value for both overall survival and recurrence-free survival analysis. Our analysis suggests that LOX is the most reliable prognostic factor for CCRC patients.
引用
收藏
页码:632 / 638
页数:7
相关论文
共 50 条
  • [1] Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma
    Lin, Shitong
    Zheng, Lingling
    Lu, Yuchao
    Xia, Qidong
    Zhou, Peng
    Liu, Zheng
    CANCER MEDICINE, 2020, 9 (22): : 8624 - 8638
  • [2] Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis
    Zhai, Wenxin
    Lu, Haijiao
    Dong, Shenghua
    Fang, Jing
    Yu, Zhuang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2020, 52 (08) : 853 - 863
  • [3] Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
    Zhang, Tian
    Pabla, Sarabjot
    Lenzo, Felicia L.
    Conroy, Jeffrey M.
    Nesline, Mary K.
    Glenn, Sean T.
    Papanicolau-Sengos, Antonios
    Burgher, Blake
    Giamo, Vincent
    Andreas, Jonathan
    Wang, Yirong
    Bshara, Wiam
    Madden, Katherine G.
    Shirai, Keisuke
    Dragnev, Konstantin
    Tafe, Laura J.
    Gupta, Rajan
    Zhu, Jason
    Labriola, Matthew
    McCall, Shannon
    George, Daniel J.
    Ghatalia, Pooja
    Dayyani, Farshid
    Edwards, Robert
    Park, Michelle S.
    Singh, Rajbir
    Jacob, Robin
    George, Saby
    Xu, Bo
    Zibelman, Matthew
    Kurzrock, Razelle
    Morrison, Carl
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [4] The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma
    Lei, Guojie
    Tang, Lusheng
    Yu, Yanhua
    Bian, Wenxia
    Yu, Lingyan
    Zhou, Junyu
    Li, Yanchun
    Wang, Ying
    Du, Jing
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [5] A Specific Gene Expression Signature Characterizes Metastatic Potential in Clear Cell Renal Cell Carcinoma
    Sanjmyatav, Jimsgene
    Steiner, Thomas
    Wunderlich, Heiko
    Diegmann, Julia
    Gajda, Mieczyslaw
    Junker, Kerstin
    JOURNAL OF UROLOGY, 2011, 186 (01) : 289 - 294
  • [6] Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma
    Li, Feng
    Jin, Yi
    Pei, Xiaolu
    Guo, Peiyuan
    Dong, Keqin
    Wang, Haoyuan
    Chen, Yujia
    Guo, Peng
    Meng, Ling-Bing
    Wang, Zhiyu
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 92
  • [7] Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma
    Cui, Hao
    Xu, Lei
    Li, Zhi
    Hou, Ke-Zuo
    Che, Xiao-Fang
    Liu, Bo-Fang
    Liu, Yun-Peng
    Qu, Xiu-Juan
    ONCOLOGY LETTERS, 2020, 20 (02) : 1573 - 1584
  • [8] ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma
    Shao, Yuan
    Wu, Bo
    Yang, Zhen
    Liu, Zihao
    Ma, Yuan
    Huang, Hua
    Liu, Yang
    Wang, Zeyuan
    Hu, Weijing
    Wang, Yong
    Niu, Yuanjie
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (04) : 549 - +
  • [9] CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
    Arakaki, Ryuichiro
    Yamasaki, Toshinari
    Kanno, Toru
    Shibasaki, Noboru
    Sakamoto, Hiromasa
    Utsunomiya, Noriaki
    Sumiyoshi, Takayuki
    Shibuya, Shinsuke
    Tsuruyama, Tatsuaki
    Nakamura, Eijiro
    Ogawa, Osamu
    Kamba, Tomomi
    CANCER MEDICINE, 2016, 5 (10): : 2920 - 2933
  • [10] Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma
    White-Al Habeeb, Nicole M.
    Di Meo, Ashley
    Scorilas, Andreas
    Rotondo, Fabio
    Masui, Olena
    Seivwright, Annetta
    Gabril, Manal
    Girgis, Andrew H. A.
    Jewett, Michael A.
    Yousef, George M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (06) : 531 - 541